Dr. Zheng joined Zymeworks in October 2024 and currently serves as our Vice President, Regulatory Affairs. He brings over 13 years of global regulatory experience to Zymeworks, having previously supported, led and overseen regulatory strategies and approvals for more than 20 development programs across all stages of product development. Before joining Zymeworks, Dr. Zheng headed up the Clinical Regulatory, Regulatory Operations and Quality System functions at NGM Biopharmaceuticals. Prior to NGM, He was a Global Regulatory Team Leader at Seagen Inc. He started his global regulatory career with Bayer. Dr. Zheng holds a Ph.D. in Interdisciplinary Biomedical Sciences from the Weldon School of Biomedical Engineering at Purdue University, as well as a Master of Science in Applied Statistics from Purdue University. He received his B.Sc. in Biochemistry from The Hong Kong University of Science and Technology. Dr. Zheng has held the Regulatory Affairs Certification (RAC-US) since 2011.